Literature DB >> 15292627

Predicting long-term outcome in group treatment of atopic dermatitis.

Ulrich Stangier1, Anke Ehlers, Uwe Gieler.   

Abstract

BACKGROUND: Psychological group treatments are effective adjuncts to dermatological treatments in improving dermatological symptoms and quality of life. However, no data are available on variables that may predict which patients benefit from such group treatments.
METHODS: On the basis of data from the Marburg group treatment study, we explored which variables are associated with successful treatment. Treatment outcome was defined by a marked reduction of dermatological symptoms at 1-year follow-up.
RESULTS: Regardless of the treatment condition, a high pretreatment level of scratching, a low serum IgE level, low scores on the internal Health Locus of Control Scale and a high frequency of coping-related cognitions regarding itching predicted good outcome at 1 year. Logistic regression analyses indicated that the predictive power of locus of control and itch-related cognitions differed between different treatment conditions.
CONCLUSION: In patients with atopic dermatitis, indication for psychological treatment may be based on the assessment of psychological target problems including excessive scratching and dysfunctional cognitions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15292627     DOI: 10.1159/000078846

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  3 in total

Review 1.  Pruritus: management algorithms and experimental therapies.

Authors:  Martin Steinhoff; Ferda Cevikbas; Akihiko Ikoma; Timothy G Berger
Journal:  Semin Cutan Med Surg       Date:  2011-06

2.  [Somatoform pruritus: a psychosomatic disease model].

Authors:  V Niemeier; C M Höring
Journal:  Hautarzt       Date:  2013-06       Impact factor: 0.751

Review 3.  Comprehensive Approach: Current Status on Patient Education in Atopic Dermatitis and Other Allergic Diseases.

Authors:  Stephan Traidl; Claudia Lang; Peter Schmid-Grendelmeier; Thomas Werfel; Annice Heratizadeh
Journal:  Handb Exp Pharmacol       Date:  2022
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.